Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95

Craig-Hallum維持GeneDx Holdings(WGS.US)買入評級，上調目標價至95美元

moomoo資訊 · 10/30 06:31 · 評級/大行評級

Craig-Hallum analyst William Bonello maintains $GeneDx Holdings (WGS.US)$ with a buy rating, and adjusts the target price from $70 to $95.

According to TipRanks data, the analyst has a success rate of 62.1% and a total average return of 30.8% over the past year.

AnalystRecentRatingAutoNews_83176336882815_20241030_4f0b7c3b10cf5b9a5b72309dbe6775fc0a61246a_1730395832584168_mm_en

Furthermore, according to the comprehensive report, the opinions of $GeneDx Holdings (WGS.US)$'s main analysts recently are as follows:

GeneDx has exhibited a substantial third-quarter revenue surplus. Despite robust growth and execution, the current valuation reflects a significant premium. Estimates for revenue from 2024 to 2026 have been heightened by 8%-9%. Additionally, the company's management has been recognized for executing one of the most remarkable and swift revivals in the industry.
Following a robust Q3 report where revenue exceeded expectations by 18%, the company has once more increased its fiscal year revenue outlook. Significantly, GeneDx achieved its profitability objectives much earlier than anticipated.

Note:

TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.

Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.

TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.

Craig-Hallum分析師William Bonello維持$GeneDx Holdings (WGS.US)$買入評級，並將目標價從70美元上調至95美元。

根據TipRanks數據顯示，該分析師近一年總勝率為62.1%，總平均回報率為30.8%。

AnalystRecentRatingAutoNews_83176336882815_20241030_4f0b7c3b10cf5b9a5b72309dbe6775fc0a61246a_1730395832584168_mm_tc

此外，綜合報道，$GeneDx Holdings (WGS.US)$近期主要分析師觀點如下：

GenedX顯示出可觀的第三季度收入盈餘。儘管增長強勁，執行力強勁，但當前的估值反映了可觀的溢價。對2024年至2026年的收入的估計提高了8％-9％。此外，該公司的管理層因執行業內最引人注目和最迅速的復興之一而獲得認可。
繼第三季度強勁的報告中，收入超出預期18％之後，該公司再次提高了其財年收入前景。值得注意的是，GenedX實現盈利目標的時間比預期的要早得多。

提示:

TipRanks為獨立第三方，提供金融分析師的分析數據，並計算分析師推薦的平均回報率和勝率。提供的信息並非投資建議，僅供参考。本文不對評級數據和報告的完整性與準確性做出認可、聲明或保證。

TipRanks提供每位分析師的星級，分析師星級代表分析師所有推薦的過往表現，通過分析師的總勝率和平均回報率综合計算得出，星星越多，則該分析師過往表現越優異，最高爲5颗星。

分析師總勝率為近一年分析師的評級成功次數占總評級次數的比率。評级的成功與否，取決於TipRanks的虚擬投資組合是否從該股票中產生正回報。

總平均回報率為基於分析師的初始評級創建虚擬投資組合，並根據評級變化對組合進行調整，在近一年中該投資組合所獲得的回報率。

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95

Craig-Hallum Maintains GeneDx Holdings(WGS.US) With Buy Rating, Raises Target Price to $95

風險及免責聲明

聲明